Comparison

Box5 (TFA) European Partner

Item no. HY-123071A-1mg
Manufacturer MedChem Express
Amount 1 mg
Category
Type Reagents
Specific against other
Purity 94.71
Formula C32H51F3N6O15S2
Citations [1]Jenei V, et al. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19473-8.
Smiles CC(C)C[C@@H](C(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CS)NC(CNC([C@H](CC(O)=O)NC([C@H](CCSC)NC(OC(C)(C)C)=O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
ECLASS 10.1 42051003
ECLASS 11.0 42051003
UNSPSC 12000000
Available
Product Description
Box5 TFA is a potent Wnt5a antagonist. Box5 TFA inhibits Wnt5a signaling and inhibits Wnt5a-mediated Ca2+ release. Box5 TFA inhibits cell migration. Box5 TFA has the potential for the research of melanoma[1].
StorageTemperature
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
880.90
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 250 mg/mL (ultrasonic)|H2O : 5 mg/mL (ultrasonic)
Manufacturers Target
Wnt
Pathway
Stem Cell/Wnt
Manufacturers Product type
Peptides

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close